AGP Executive Report
Last update: 5 hours agoFDA Oversight: The American Medical Association is urging the FDA to apply drug-like scientific standards to botanical products, including cannabis, and to require stronger research on safety and effectiveness. CBD Quality: Hudson Valley small-batch producers are highlighting traceable sourcing, batch codes and clear milligram counts as ways to distinguish carefully made CBD products from poorly labeled ones. Hemp Restrictions: A looming federal crackdown on hemp-derived products could remove some CBD and THC items from U.S. shelves in December, leaving businesses and consumers uncertain about what will remain legal.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.